Loading...
Loading...
Browse all stories on DeepNewz
VisitWhich institution will first collaborate with Columbia on GET AI model by mid-2025?
MBZUAI • 25%
Carnegie Mellon • 25%
Harvard University • 25%
Other • 25%
Official collaboration announcements from research institutions
Columbia Researchers Develop AI Model GET for AI4BIO to Predict Gene Activity in 213 Cell Types, Advancing Cancer and Genetic Disease Research
Jan 9, 2025, 05:40 PM
Researchers at Columbia University, in collaboration with MBZUAI and Carnegie Mellon, have developed a new artificial intelligence model named GET. This model can accurately predict gene activity across 213 different cell types, providing insights into the inner workings of human cells. The advancement is seen as a breakthrough in understanding gene regulation, which could have significant implications for fields such as cancer research and genetic diseases. The project aims to enhance the capabilities of AI in biological research, potentially leading to virtual simulations of human cells, a long-sought goal in biology.
View original story
European Space Agency • 25%
Other • 25%
NOAA • 25%
NASA • 25%
Microsoft • 25%
Amazon • 25%
Google • 25%
Other • 25%
Google • 25%
Microsoft • 25%
OpenAI • 25%
Amazon • 25%
Other • 25%
Technical University of Munich • 25%
Beijing Institute of Technology • 25%
Moscow State University • 25%
Other • 25%
Natural Language Processing • 25%
Computer Vision • 25%
Autonomous Systems • 25%
Google • 25%
Microsoft • 25%
Apple • 25%
Other • 25%
Partnership with a tech company • 25%
Partnership with a financial institution • 25%
Partnership with a government entity • 25%
No major partnership announced • 25%
Amazon • 25%
Microsoft • 25%
Other • 25%
Google • 25%
National Oceanic and Atmospheric Administration (NOAA) • 25%
Other • 25%
UK Met Office • 25%
European Centre for Medium-Range Weather Forecasts (ECMWF) • 25%
Google • 25%
Microsoft • 25%
Amazon • 25%
Other • 25%
Other/None • 25%
MIT • 25%
Stanford • 25%
Carnegie Mellon • 25%
Virtual Cell Simulation • 25%
Gene Regulation Analysis • 25%
Other • 25%
Drug Development • 25%